tiprankstipranks
Adaptive, NeoGenomics partner to expand access to disease monitoring
PremiumThe FlyAdaptive, NeoGenomics partner to expand access to disease monitoring
18d ago
NeoGenomics downgraded to Hold at Benchmark on below-peer margins
Premium
The Fly
NeoGenomics downgraded to Hold at Benchmark on below-peer margins
19d ago
NeoGenomics downgraded to Hold from Buy at Benchmark
Premium
The Fly
NeoGenomics downgraded to Hold from Buy at Benchmark
19d ago
Natera expands patent infringement lawsuit against NeoGenomics
PremiumThe FlyNatera expands patent infringement lawsuit against NeoGenomics
2M ago
NeoGenomics price target raised to $19 from $18 at BofA
Premium
The Fly
NeoGenomics price target raised to $19 from $18 at BofA
2M ago
NeoGenomics initiated with a Buy at Jefferies
Premium
The Fly
NeoGenomics initiated with a Buy at Jefferies
2M ago
NeoGenomics Reports Strong Q3 2024 Revenue Growth
PremiumCompany AnnouncementsNeoGenomics Reports Strong Q3 2024 Revenue Growth
3M ago
Is NEO a Buy, Before Earnings?
Premium
Pre-Earnings
Is NEO a Buy, Before Earnings?
3M ago
Natera says court orders injunction against NeoGenomics’ accused RaDaR assay
Premium
The Fly
Natera says court orders injunction against NeoGenomics’ accused RaDaR assay
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100